Prime Medicine, Inc. (PRME)
NASDAQ: PRME · IEX Real-Time Price · USD
5.23
-0.08 (-1.51%)
Jul 22, 2024, 10:09 AM EDT - Market open
Prime Medicine Employees
Prime Medicine had 234 employees as of December 31, 2023. The number of employees increased by 59 or 33.71% compared to the previous year.
Employees
234
Change (1Y)
59
Growth (1Y)
33.71%
Revenue / Employee
$2,526
Profits / Employee
-$873,919
Market Cap
637.36M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pediatrix Medical Group | 5,450 |
| PetIQ | 1,933 |
| Exscientia | 483 |
| Phathom Pharmaceuticals | 452 |
| IGM Biosciences | 224 |
| UroGen Pharma | 201 |
| Arcturus Therapeutics Holdings | 180 |
| Entrada Therapeutics | 159 |
PRME News
- 2 months ago - Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - Alphabet Bought Up Two Slumping Stocks - Barrons
- 2 months ago - Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) - GlobeNewsWire
- 3 months ago - Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) - GlobeNewsWire
- 3 months ago - Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings - GlobeNewsWire
- 5 months ago - Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire